Real-World Benefits of Mepolizumab in Patients With Severe Asthma and Comorbid GERD or Anxiety/Depression: Post Hoc Analysis of REALITI-A

被引：0

作者：

Liu, Mark ^{[1
]}

Bagnasco, Diego ^{[2
]}

Matucci, Andrea ^{[3
]}

Pilette, Charles ^{[4
]}

Price, Robert ^{[5
]}

Maxwell, Aoife ^{[5
]}

Alfonso-Cristancho, Rafael ^{[6
]}

Jakes, Rupert ^{[7
]}

Lee, Jason ^{[8
]}

Cheema, Amarjit ^{[9
]}

Howarth, Peter ^{[10
]}

机构：

[1] Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD USA

[2] Univ Genoa, Osped Policlin San Martino, Genoa, Italy

[3] Univ Florence, Florence, Italy

[4] Clin Univ St Luc, Brussels, Belgium

[5] GSK, Stevenage, Herts, England

[6] GSK, Collegeville, PA USA

[7] GSK, London, England

[8] Toronto Allergy & Asthma Clin, Toronto, ON, Canada

[9] Alpha Med Res, Mississauga, ON, Canada

[10] GSK, Brentford, Middx, England

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2023年 / 151卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

061

引用

页码：AB20 / AB20

页数：1

共 50 条

[41] Real-world safety of treatment with mepolizumab and reslizumab in patients with severe eosinophilic asthma
Ordonez Pinilla, Karen A.
Moya Camacho, Beatriz
Fernandez Rodriguez, Consuelo
Fernandez Crespo, Jesus F.
Garcia Moguel, Ismael
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB99 - AB99
[42] Efficacy and safety of mepolizumab in a real-world cohort of patients with severe eosinophilic asthma
Pertzov, Barak
Avraham, Unterman
Osnat, Shtraichman
Dorit, Shitenberg
Dror, Rosengarten
Reuven, Kramer Mordechai
JOURNAL OF ASTHMA, 2021, 58 (01) : 79 - 84
[43] Efficacy and Safety of Mepolizumab in a Real-World Cohort of Patients with Severe Eosinophilic Asthma
Pertzov, B.
Unterman, A.
Shtraichman, O.
Shitenberg, D.
Rosengarten, D.
Kramer, M. R.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
[44] The Clinical Benefit Of Mepolizumab Treatment Is Independent Of Baseline Maintenance Oral Corticosteroid Use: Results From The Real-World REALITI-A Study
Liu, Mark
Schleich, Florence
Lee, Jason
Pelaia, Girolamo
Sanchez, Carlos Almonacid
Heaney, Liam
Alfonso-Cristancho, Rafael
Jakes, Rupert
Price, Robert
Maxwell, Aoife
Howarth, Peter
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB147 - AB147
[45] Real-World Impact of Mepolizumab on Pediatric and Adolescent Patients With Severe Asthma in the United States
Corbridge, T.
Mahendran, M.
Hilts, A.
Zhang, K.
Laliberte, F.
Deb, A.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
[46] Effectiveness of mepolizumab on severe asthma in Argentina: a real-world cohort study
Colodenco, Daniel
Yanez, Anahi
Promencio, Federico
Gattolin, Gabriel
Maillo, Martin
Bergna, Miguel
Stok, Ana
Sivori, Martin
Vinuesa, Miguel
Guendulain, Silvana
Mengarelli, Maria Cecilia
Galperin, Angeles
Jousse, Maria Laura
Zambelli, Martin
Perelli, Lucas
Noibi, Saeed
EUROPEAN RESPIRATORY JOURNAL, 2024, 64
[47] WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN PATIENTS WITH SEVERE ASTHMA TREATED WITH MEPOLIZUMAB IN A REAL-WORLD SETTING
Alfonso-Cristancho, R.
Canonica, W.
Price, R. G.
Yang, S.
Jakes, R. W.
Maxwell, A.
Howarth, P.
VALUE IN HEALTH, 2022, 25 (07) : S567 - S567
[48] A real-world study of inhaled corticosteroid use in patients with severe eosinophilic asthma treated with mepolizumab
Corren, Jonathan
Silver, Jared
Molfino, Nestor A.
Bogart, Michael
Packnett, Elizabeth
McMorrow, Donna
Wu, Juan
Hahn, Beth
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 128 (02) : 184 - +
[49] Benefits of omalizumab on anxiety and depression in patients with severe asthma
Uzer, Fatih
Ozbudak, Omer
CASPIAN JOURNAL OF INTERNAL MEDICINE, 2018, 9 (03) : 228 - 231
[50] Real-world Effectiveness of Mepolizumab in Severe Eosinophilic Asthma: A Systematic Review and Meta-analysis
Li, Hongwen
Zhang, Qing
Wang, Jingru
Gao, Shengnan
Li, Chunxiao
Wang, Jianxin
Zhang, Shuhua
Lin, Jiangtao
CLINICAL THERAPEUTICS, 2021, 43 (06) : E192 - E208

← 1 2 3 4 5 →